GrantSet

Special Notice · Notice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)

Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)

Responses due2h leftJul 29, 2026, 11:00 AM EDT
Buying agencyDepartment of Health and Human Services
Sub-tierCenters for Disease Control and Prevention
OfficeCdc Office of Acquisition Services
NAICS541715 — Professional, Scientific, and Technical Services
PSCAN12
Set-asideTotal Small Business Set-Aside
PostedJul 15, 2026
DeadlineJul 29, 2026, 11:00 AM EDT
Place of performanceTucson, AZ, 85724
From the notice

Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever) The Centers for Disease Control and Prevention intends to award a sole source firm fixed price to Valley fever Solutions, INC, Valley Fever Center for Excellence (University of Arizona) to support the development, evaluation, and validation of diagnostic methods for coccidioidomycosis through collaboration with the Valley Fever Center for Excellence (VFCE). This project will leverage VFCE�s existing biospecimen repository and clinical infrastructure to support diagnostic assay development. Additional specimen collection and enhanced storage capacity will be implemented to support expanded research needs. Product or Service Code: AN12 � Health R&D Services; Applied Research NAICS Code: 541715 � Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) The anticipated period of performance is September 30, 2026,…

Excerpt as published. The complete description, attachments, and any amendments are on the official notice.

View the official notice on SAM.gov ↗

GrantSet indexes public records and is not the official application channel. Responses and applications go through SAM.gov only — the official notice there controls if anything shown here differs.